Optina Diagnostics is a company specializing in the development of hyperspectral ocular imaging to diagnose retina-related diseases. Optech helped optimize their innovative technologies used to non-invasively prevent eyesight-threatening diseases.

Grant: Applied Research and Development
Partner: Optina Diagnostics
Field: Biomedical

After the André-Laurendeau CEGEP received an Applied Research and Development (ARD) grant in 2014, Optech collaborated with Optina Diagnostics to develop a retinal camera based on hyperspectral imaging. The camera is used to obtain spectral and anatomical information from the back of the eye for early and non-invasive detection of diseases that affect vision, including age-related macular degeneration (ARMD), diabetic retinopathy (DR) and glaucoma.

“The project was a true collaboration where two teams worked in tandem to find the appropriate solution. Access to the Optech team’s expertise, equipment and laboratories was a considerable advantage for accelerating our development.”
– Jean-Philippe Sylvestre, Vice-President R&D, Optina Diagnostics

During this project, Optech helped improve the retinal camera by using digital models to validate the solutions proposed by Optina and then test them. Afterward, Optech designed and prototyped a new and improved optomechanical system for getting more accurate images of the back of the eye.

Optina Diagnostics
Cégep André-Laurendeau, partenaire Optech